Nothing Special   »   [go: up one dir, main page]

FR2397395A1 - Peptides pharmacologiques a usage therapeutique - Google Patents

Peptides pharmacologiques a usage therapeutique

Info

Publication number
FR2397395A1
FR2397395A1 FR7821087A FR7821087A FR2397395A1 FR 2397395 A1 FR2397395 A1 FR 2397395A1 FR 7821087 A FR7821087 A FR 7821087A FR 7821087 A FR7821087 A FR 7821087A FR 2397395 A1 FR2397395 A1 FR 2397395A1
Authority
FR
France
Prior art keywords
therapeutic use
pharmacological peptides
peptides
pharmacological
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7821087A
Other languages
English (en)
Other versions
FR2397395B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of FR2397395A1 publication Critical patent/FR2397395A1/fr
Application granted granted Critical
Publication of FR2397395B1 publication Critical patent/FR2397395B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention a pour objet de nouveaux peptides de formule :
FR7821087A 1977-07-13 1978-07-13 Peptides pharmacologiques a usage therapeutique Granted FR2397395A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7707781A NL7707781A (nl) 1977-07-13 1977-07-13 Psychofarmacologische peptiden.

Publications (2)

Publication Number Publication Date
FR2397395A1 true FR2397395A1 (fr) 1979-02-09
FR2397395B1 FR2397395B1 (fr) 1981-01-16

Family

ID=19828866

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7821087A Granted FR2397395A1 (fr) 1977-07-13 1978-07-13 Peptides pharmacologiques a usage therapeutique

Country Status (16)

Country Link
US (1) US4203975A (fr)
JP (1) JPS5419934A (fr)
AU (1) AU519567B2 (fr)
BE (1) BE868953A (fr)
CA (1) CA1108123A (fr)
DE (1) DE2830489A1 (fr)
DK (1) DK149454C (fr)
ES (1) ES471672A1 (fr)
FI (1) FI67367C (fr)
FR (1) FR2397395A1 (fr)
GB (1) GB2001076B (fr)
IE (1) IE47547B1 (fr)
LU (1) LU79960A1 (fr)
NL (1) NL7707781A (fr)
SE (1) SE443789B (fr)
ZA (1) ZA783713B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU530062B2 (en) * 1979-02-21 1983-06-30 Akzo N.V. Psycho-pharmacological peptides
JPH0195597U (fr) * 1987-12-17 1989-06-23
JP6056111B2 (ja) * 2013-05-22 2017-01-11 国立研究開発法人産業技術総合研究所 光分解性架橋剤、光分解性ゲル、細胞培養器具、細胞配列・分別装置、細胞配列方法、細胞分別方法、組織体形成方法および組織体
JP6431920B2 (ja) * 2013-09-17 2018-11-28 オービーアイ ファーマ，インコーポレイテッド 免疫反応を誘導する炭水化物ワクチンの組成とがんの治療におけるその使用
US10980894B2 (en) 2016-03-29 2021-04-20 Obi Pharma, Inc. Antibodies, pharmaceutical compositions and methods
NZ747262A (en) 2016-04-22 2024-12-20 Obi Pharma Inc Cancer immunotherapy by immune activation or immune modulation via globo series antigens
AU2017302038B2 (en) 2016-07-27 2024-03-21 Obi Pharma, Inc. Immunogenic/therapeutic glycan compositions and uses thereof
JP7121724B2 (ja) 2016-07-29 2022-08-18 オービーアイ ファーマ，インコーポレイテッド ヒト抗体、医薬組成物及び方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803119A (en) * 1970-04-20 1974-04-09 Daiichi Seiyaku Co Pantetheine-s-sulfonic acid derivatives and salts thereof
NL175293C (nl) * 1972-02-08 1984-10-16 Akzo Nv Werkwijze ter bereiding of vervaardiging van een farmaceutisch preparaat met psychofarmacologische werking, alsmede werkwijze voor het bereiden van een van vasopressine afgeleid peptide.

Also Published As

Publication number Publication date
DE2830489A1 (de) 1979-01-25
SE7807759L (sv) 1979-01-14
CA1108123A (fr) 1981-09-01
ZA783713B (en) 1979-07-25
IE47547B1 (en) 1984-04-18
FI782195A (fi) 1979-01-14
AU3778078A (en) 1980-01-10
LU79960A1 (fr) 1979-04-09
GB2001076A (en) 1979-01-24
JPS6220200B2 (fr) 1987-05-06
FI67367C (fi) 1985-03-11
GB2001076B (en) 1982-01-27
NL7707781A (nl) 1979-01-16
DK314978A (da) 1979-01-14
ES471672A1 (es) 1979-09-16
IE781291L (en) 1979-01-13
US4203975A (en) 1980-05-20
FR2397395B1 (fr) 1981-01-16
DK149454C (da) 1986-11-17
DK149454B (da) 1986-06-16
JPS5419934A (en) 1979-02-15
SE443789B (sv) 1986-03-10
FI67367B (fi) 1984-11-30
BE868953A (fr) 1979-01-12
AU519567B2 (en) 1981-12-10

Similar Documents

Publication Publication Date Title
BE869612A (fr) Preparation d'oligoimides
FR2430411A1 (fr) Phenethanolamines et leur utilisation therapeutique
FR2417500A1 (fr) Derives d'amino-acides cycliques dehydrogenes et leur utilisation therapeutique
FR2417510A1 (fr) 9-amino- et imino-dibenzopyrannes et leur utilisation therapeutique
FR2435248A1 (fr) Derives de 4-anilinoquinazoline, leur procede de preparation et leur application en therapeutique
FR2400517A1 (fr) Triazolo-2,4-benzodiazepines et leur utilisation therapeutique
FR2392671A1 (fr) Application pharmacologique des acides d2-3-1,4-morpholine-2-carboxyliques substitues
FR2379534A1 (fr) 1-thienyl- et furyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees
FR2383187A1 (fr) Derives du cepheme, leur procede de preparation et leur application en therapeutique
FR2370753A1 (fr) Derives du glucofurannose et leur application therapeutique
FR2362170A1 (fr) Nouvelles polyurees
FR2405246A1 (fr) Nouveaux derives de pyrrole, leur procede de preparation et leurs applications en therapeutique
IT1100442B (it) Procedimento per ridurre al minimo le proprieta' non desiderate di un rivelatore di umidita'
FR2442836A1 (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur preparation et leur utilisation therapeutique
FR2404629A1 (fr) Nouveaux tetrapeptides et leur utilisation therapeutique
FR2397395A1 (fr) Peptides pharmacologiques a usage therapeutique
FR2378016A1 (fr) 1-alkylthiophenyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees et leur application en therapeutique
FR2372165A1 (fr)
FR2358384A1 (fr) Peptides psychopharmacologiquement actifs et derives de ces peptides
FR2360583A1 (fr) B-azolylcetones utiles comme fongicides
FR2389639A1 (fr)
FR2417499A1 (fr) Mercaptoacylamino-acides halogenes et leur utilisation therapeutique
FR2381788A1 (fr) 1-thio-beta-d-glucopyrannosides de (phosphine trisubstituee)-or (i) et leur application en therapeutique
FR2383944A1 (fr) Derives de bis-benzimidazolyle substitues, leur procede de preparation et leur application en therapeutique
FR2387981A1 (fr) Spiro(indoline-3,4'-piperidine)s et composes apparentes, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse